GENOWAY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.28 EUR | -1.61% |
|
+3.13% | -6.96% |
| 2023 | GenOway: sharp rise, broker initiates buy recommendation | CF |
| 2023 | GENOWAY : Euroland initiates buy coverage | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENOWAY | Other Biotechnology & Medical Research | -1.61% | +3.13% | -6.96% | +14.75% | +139.11% | 42.25M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ALGEN Stock
- Charts genOway
- Comparison Chart